Medical Journals To Follow New Policy


BOSTON-Two prominent American medical journals will no longer let pharmaceutical companies determine conclusions of studies. Instead, editors at The New England Journal of Medicine and The Lancet will rely on the researchers who conducted the work to write the conclusions to their studies.

This decision comes after reported cases of drug companies influencing and pressuring editorial staff members to print articles that incorrectly favored their product. In a few reported cases, companies attempted to block publication of a study if it was not favorable for their company.

Officials at both journals say this decision will give the power to the scientist conducting the experiment. While many studies are funded by pharmaceutical companies, the researchers will now have more independence in reporting their findings, rather than what a pharmaceutical company representative would like to have published.

Information from

Related Videos
Andrea Flinchum, 2024 president of the Certification Board of Infection Control and Epidemiology, Inc (CBIC) explains the AL-CIP Certification at APIC24
Association for Professionals in Infection Control and Epidemiology  (Image credit: APIC)
Lila Price, CRCST, CER, CHL, the interim manager for HealthTrust Workforce Solutions; and Dannie O. Smith III, BSc, CSPDT, CRCST, CHL, CIS, CER, founder of Surgicaltrey, LLC, and a central processing educator for Valley Health System
Jill Holdsworth, MS, CIC, FAPIC, CRCST, NREMT, CHL
Jill Holdsworth, MS, CIC, FAPIC, CRCSR, NREMT, CHL, and Katie Belski, BSHCA, CRCST, CHL, CIS
Baby visiting a pediatric facility  (Adobe Stock 448959249 by
Antimicrobial Resistance (Adobe Stock unknown)
Anne Meneghetti, MD, speaking with Infection Control Today
Patient Safety: Infection Control Today's Trending Topic for March
Related Content